Vitamin D Dynamics in Women
Vitamin D Dynamics in Pregnant Women and Non-Pregnant Women of Reproductive Age
Cornell University
160 participants
Oct 28, 2024
OBSERVATIONAL
Conditions
Summary
The goal of this project is to utilize stable isotopically labeled vitamin D3 and state of the art mass spectrometric methodology to assess vitamin D dynamics during pregnancy in relation to relation to obesity and vitamin D binding protein genotype. At the conclusion of this study, the investigators will have obtained novel information on the absorption and utilization of vitamin D in women and the degree to which vitamin D utilization during pregnancy is impacted by genetic ancestry, vitamin D binding protein concentration and genotype and by excess adiposity. The long-term goal is to better understand the unique metabolism of vitamin D during pregnancy.
Eligibility
Inclusion Criteria6
- Self-reported White and Black women
- Age 20-39
- Body mass index (BMI) 1or pre-pregnancy BMI (If currently pregnant) either 18.5-24.9 kg/m2 or greater than or equal to 30 kg/m2
- Singleton pregnancy
- Recruited in first trimester, second trimester, or third trimester
- No pregnancy complications
Exclusion Criteria15
- BMI or pre-pregnancy BMI \<18.5 kg/m2
- Human immunodeficiency virus (HIV) infection
- Diagnosed eating disorder
- Malabsorption disease
- Diabetes
- Elevated diastolic blood pressure (\>110 mm/Hg)
- Steroid use
- Substance abuse history
- Current use of medications known to influence vitamin D or calcium homeostasis
- Plans to travel to lower latitude during the 20-day study period
- Plans to become pregnant during the study period (non-pregnant only)
- Refuses to discontinue tanning bed use during study period
- Refuses to discontinue vitamin or mineral supplement use during study period (non-pregnant only)
- Gestational diabetes
- Pregnancy hypertension
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
tracer dose of deuterated vitamin D3
tracer dose of deuterated vitamin D3
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02705287